rdy+acl will ruin gsk

GSK is the second largest Pharma in the World and they need Blockbusters to stay alive .

Once GSK losing the battle against Reddy they will pull Arixtra from the market or selling the drug to other Company .

GSK cant selling the drug lower than Reddy because the manufacturing cost are much higher and it will not profitbale for GSK .

I think RDY and ACL has huge chance to make a lot of money with Fonda .

Super Great Buying Opportunity Folks !